We are live on ! Find out more
DTA

Disruptive Technology Advisers Portfolio holdings

AUM $724K
1-Year Est. Return 65.23%
This Fund
S&P 500
This Quarter Est. Return
-42.49%
1 Year Est. Return
-65.23%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$724K
AUM Growth
-$31.6M
Cap. Flow
-$28.5M
Cap. Flow %
-3,940.62%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
HIMS icon
Hims & Hers Health
HIMS
+$16.7M
2
PATH icon
UiPath
PATH
+$6.25M
3
ME
23andMe Holding Co
ME
+$5.62M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ME
1
DELISTED
23andMe Holding Co
ME
$724K 100%
9,451
-61,596
-87% -$5.62M
HIMS icon
2
Hims & Hers Health
HIMS
$6.5B
-2,542,398
Closed -$16.7M
PATH icon
3
UiPath
PATH
$5.62B
-145,034
Closed -$6.25M

Similar funds

Disruptive Technology Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, Disruptive Technology Advisers held 3 positions worth $724K, down 98% from $32.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Disruptive Technology Advisers withdrew a net $28.5M in Q1 2022, closing 2 positions and reducing 1 holding. Its most notable exit was Hims & Hers Health, an estimated $16.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 81% a quarter earlier, followed by Technology.

  • Disruptive Technology Advisers's biggest Q1 2022 reduction was 23andMe Holding Co, cutting an estimated $5.62M.
  • Disruptive Technology Advisers fully exited Hims & Hers Health in Q1 2022, selling an estimated $16.7M.
  • Disruptive Technology Advisers's ten largest holdings make up 100% of its $724K portfolio in Q1 2022.
  • Disruptive Technology Advisers opened 0 new positions and closed 2 in Q1 2022.
  • Disruptive Technology Advisers's portfolio value fell 98% quarter-over-quarter to $724K.

Based on Disruptive Technology Advisers's 13F filing for Q1 2022, filed 9 May 2022.